Gabriel Liguori

Gabriel Liguori is the CEO at TissueLabs and was previously with Sociedade Brasileira de Cirurgia Cardiovascular. Gabriel has also worked as a PhD Researcher with the Cardiovascular Regenerative Medicine (CAVAREM) Research Group and as a Fellow with Líderes Estudar. In addition, they have also served as the Co-Founder and Chairman of DBLACCV and as an Intern with Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP).

Gabriel Liguori has a Doctor of Philosophy (PhD) in Cardiovascular Regenerative Medicine from the University of Groningen, a Doctor of Philosophy (PhD) in Thoracic and Cardiovascular Surgery from Universidade de São Paulo, and a Doctor of Medicine (MD) in Medicine from Universidade de São Paulo. Gabriel is certified by the American Heart Association and American Stroke Association as an Advanced Cardiovascular Life Support (ACLS) Provider, and by the American College of Surgeons as a Trauma Emergency Assessment & Management (TEAM) provider.

A direct report to Gabriel Liguori is and Emerson Moretto - CTO.